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We and others have shown that regulatoryT cells (Treg) accumulate dramatically with age in
both humans and mice. SuchTreg accrual contributes to age-related immunosenescence as
they reduce the response to tumors and parasite infection. While we reported earlier that
agedTreg have decreased expression of the pro-apoptotic molecule Bim and germline dele-
tion of Bim promoted earlier accumulation of Treg, it remains unclear whether the effects
of Bim are: (i) Treg intrinsic and (ii) dominant to other BH3-only pro-apoptotic molecules.
Further, the mechanism(s) controlling Bim expression in aged Treg remain unclear. Here
we show that Treg-specific loss of Bim is sufficient to drive Treg accrual with age and that
additional loss of the downstream apoptotic effectors Bax and Bak did not exacerbate Treg
accumulation. Further, our results demonstrate that a subpopulation of Treg expands with
age and is characterized by lower expression of CD25 (IL-2Rα) and Bim. Mechanistically,
we found that IL-2 levels decline with age and likely explain the emergence of CD25loBimlo
Treg because Treg in IL-2−/− mice are almost entirely comprised of CD25loBimlo cells, and
IL-2 neutralization increases CD25loBimlo Treg in both young and middle-aged mice. Inter-
estingly, theTreg population in aged mice had increased expression of CD122 (IL-2/IL-15Rβ)
and neutralization or genetic loss of IL-15 led to less Treg accrual with age. Further, the
decreased Treg accrual in middle-aged IL-15−/− mice was restored by the additional loss of
Bim (IL-15−/−Bim−/−). Together, our data show that aging favors the accrual of CD25lo Treg
whose homeostasis is supported by IL-15 as IL-2 levels become limiting. These data have
implications for manipulating Treg to improve immune responses in the elderly.
Keywords: CD25, Bim, IL-2, IL-15, aging,Treg
INTRODUCTION
Aging is associated with declining immune function, which con-
tributes to increased infectious diseases, increased cancer, and
decreased vaccine efficacy in the elderly. The aging immune sys-
tem is characterized by a progressive deterioration in the adaptive
immune system, particularly affecting T cells (Linton and Dor-
shkind, 2004; Maue et al., 2009). Factors contributing to T cell
dysfunction with age include: (i) thymic involution and decreased
naïve T cell production (Sempowski et al., 2002; Hale et al.,
2006); (ii) impaired TCR signaling and immune synapse forma-
tion (Miller et al., 1997; Miller, 2000; Tamir et al., 2000; Garcia and
Miller, 2002); (iii) impaired T cell proliferation (Murasko et al.,
1987; Haynes et al., 2005); (iv) CD8+ T cell clonal expansion dri-
ven by chronic infections (Khan et al., 2002; Ouyang et al., 2003;
Clambey et al., 2005). While many of these effects are T cell intrin-
sic, recent work has found that regulatory T cell (Treg) frequencies
increase dramatically with age in both mice and humans and may
contribute substantially to impaired T cell responses in aged hosts
(Valmori et al., 2005; Nishioka et al., 2006; Sharma et al., 2006;
Lages et al., 2008; Agius et al., 2009).
Regulatory T cells, a specialized subset of CD4+FoxP3+ T cells,
are known to control the intensity of immune responses through
modulating the activation and function of both effector T cells
and antigen-presenting cells (Miyara and Sakaguchi, 2007; Onishi
et al., 2008). The functionality of aged Treg have not been well stud-
ied, however we have shown that aged FoxP3+ Treg have an equal
or increased in vitro suppressive capacity compared to young Treg
(Lages et al., 2008). In vivo, depletion of CD25+ Treg allowed for
a more robust CD4+ T cell response against Leishmania major in
aged mice, suggesting increased Treg in the aged can dampen effec-
tor T cell activation (Lages et al., 2008). Additionally, Treg accrual
with age has been shown to inhibit anti-tumor responses (Sharma
et al., 2006). Thus, aged Treg appear to be functional in vivo and
Treg accrual may contribute significantly to immunosenescence in
aging.
Many studies have looked at the factors involved in Treg home-
ostasis in young mice, particularly the γc cytokines IL-2, IL-7,
and IL-15. The receptor for IL-2 is comprised of CD25 (IL-2Rα),
CD122 (IL-2/15Rβ), and CD132 (IL-2/15/7Rγ). IL-2 shares the
IL-2/15Rβ receptor with IL-15, and the γc receptor (CD132) with
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both IL-15 and IL-7. IL-2 is the dominant cytokine required for
Treg survival and homeostasis, as the loss of IL-15 or IL-7 signal-
ing does not substantially affect the frequency of CD4+ cells that
are Treg when IL-2 is present (Burchill et al., 2007; Bayer et al.,
2008; Vang et al., 2008). However, CD132 and to a lesser extent
CD122-deficient mice have a more profound loss of Treg com-
pared to IL-2 or CD25 deficient mice, suggesting that IL-15 and/or
other γc cytokines also contribute to Treg homeostasis (Fontenot
et al., 2005a). All of these studies examining the requirements for
cytokine signaling in Treg development and survival have been
done in young mice, and the role for the γc cytokines in aged Treg
homeostasis is unclear.
Our previous study showed that Bim plays a major role in Treg
homeostasis and that Bim levels decline significantly in aged Treg
(Chougnet et al., 2011). Further germline deletion of Bim led to
significantly faster accrual of Treg (Chougnet et al., 2011). Here,
we found that Treg-specific loss of Bim was sufficient to drive Treg
accrual and that Bim was the dominant pro-apoptotic molecule
driving Treg accrual. Further, decreased Bim levels in aged Treg is
reflected by decreased Bim mRNA and increased Bim turnover.
Additionally, declining IL-2 levels with age resulted in reduced
levels of CD25 and increased levels of CD122 which foster Treg
dependence upon IL-15, which, in turn, functions to restrain the
remaining Bim in aged Treg.
MATERIALS AND METHODS
MICE
C57BL/6 mice were purchased from either Taconic Farms (Ger-
mantown, NY, USA) or the National Institutes of Aging colony
located at Charles River Laboratories (Wilmington, MA, USA).
B6.129P2-Il2tm1Hor/J (IL-2−/−) mice and their C57BL/6 controls
were purchased from The Jackson Laboratory (Bar Harbor, ME,
USA). B6.SJL-Ptprca Pepcb/BoyJ mice on the C57BL/6 background
were purchased from The Jackson Laboratory and aged in house.
Bim−/− mice have been backcrossed to C57BL/6 mice for at least
20 generations. Bimf/f mice were generated at the Walter and Eliza
Hall Institute as part of a collaborative effort with Dr. P. Bouillet.
Briefly, a targeting vector was created by flanking coding exons 2,
3, and 4 of Bim with loxP sites. The vector was electroporated into
C57BL/6 embryonic stem (ES) cells and homologously recom-
bined ES cells were selected with hygromycin. The hygromycin
cassette was removed by crossing the Bimf/f mice with B6.Cg-
Tg(ACTFLPe)9205Dym/J (Jackson Labs) to generate a Bim floxed
allele that could be crossed to tissue – specific cre transgenic mice
to achieve tissue-specific deletion of Bim. Offspring from this cross
were screened for removal of the Hygromycin cassette and main-
tenance of the conditional Bim allele. Mice were then bred to
Cre-expressing mice and offspring screened for lack of the ACT-
FLPe allele. Lck-Cre Baxf/fBak−/− mice were a gift from Dr. S.
Korsmeyer and were previously described (Takeuchi et al., 2005).
IL-15-deficient mice on the C57BL/6 background were purchased
from Taconic Farms, mated with the Bim−/− mice to generate IL-
15−/− Bim−/− mice, and aged in house. FoxP3-IRES-DTR-GFP
knock-in C57BL/6 mice (Kim et al., 2007) and FoxP3-Cre mice
(Rubtsov et al., 2008) were a gift from Dr. A. Rudensky. FoxP3-
IRES-DTR-GFP mice were aged in house. FoxP3-Cre mice were
mated with Bimf/f mice and aged in house. Mice were housed
under specific pathogen-free conditions. All animal protocols were
reviewed and approved by our Institutional Animal Care and Use
Committee.
FLOW CYTOMETRY
Spleens, lymph nodes (inguinal, axillary, and brachial), and thymi
were harvested and crushed through 100µm filters (BD Falcon)
to generate single-cell suspensions. About 1× 106 cells were sur-
face stained with Abs against CD4 (BD Biosciences, San Diego,
CA, USA), CD25 (eBioscience, San Diego, CA, USA), CD44 (eBio-
science), CD122 (Biolegend, San Diego, CA, USA), CD45.2 (eBio-
science) and intracellularly for FoxP3 (eBioscience), Bim (Cell Sig-
naling Technology, Beverly, MA, USA), and Ki67 (eBioscience). All
intracellular stains were performed using the eBioscience FoxP3
staining protocol. For detection of Bim, secondary anti-rabbit
IgG Abs were used (Jackson ImmunoResearch Laboratories, West
Grove, PA, USA; Invitrogen, Carlsbad, CA, USA; or Cell Signal-
ing Technology). Data were acquired on an LSRII flow cytometer
(BD Biosciences), analyzed using FACSDiva software (BD Bio-
sciences), and histogram overlays were prepared using FlowJo
software (Tree Star).
ADOPTIVE TRANSFERS
Spleen cells from young (3–4 months) and old (19–23 months)
FoxP3-IRES-DTR-GFP mice were enriched for CD4+ cells using
the negative selection MACS CD4+ T cell Isolation Kit II (Mil-
tenyi Biotec, Auburn, CA, USA) and stained with CD4 antibody.
CD4+FoxP3GFP+ cells were then sorted by FACSAria (BD Bio-
sciences), and>85% purity was obtained. About 5× 105 cells were
injected i.v. into young (2 months) or aged (15 months) C57BL/6
congenic CD45.1 recipient mice. The recipient mice were sacri-
ficed either 1.5 or 10 days post-transfer, spleens were harvested,
and single-cell suspensions were stained for CD4, CD45.2, CD25,
and intracellularly for FoxP3. Cells were fixed with 4% methanol-
free formaldehyde (Polysciences, Warrington, PA, USA), instead of
the eBioscience FoxP3 fix-perm buffer, to better retain GFP within
the cells.
IN VIVO CYTOKINE CAPTURE ASSAY
IL-2 in vivo cytokine capture assay (IVCCA) was performed as
described (Finkelman and Morris, 1999; Finkelman et al., 2003).
Briefly, young (2–5 months), middle-aged (11–12 months), and
old (>15 months) C57BL/6 mice were injected i.v. with 10µg
of biotinylated anti-IL-2 capture antibody (JES6-5H4-BD Bio-
sciences), or with PBS as a control, and mice were bled 24 h
later and serum was collected. Ninety-six-well Costar plates were
coated overnight with anti-IL-2 JES61A12 (eBioscience) and then a
luminescent ELISA was performed. For the cytokine:anti-cytokine
mAb standard, 100 ng of recombinant mouse IL-2 (R&D) was
incubated with 10µg of the anti-IL-2 capture antibody (JES6-
5H4) for 10 min, and 100 ng/ml aliquots were stored in −80° C
freezer. The IL-2 concentration obtained from our PBS control
was subtracted from our young and old samples to remove the
ELISA background.
IN VIVO CYTOKINE NEUTRALIZATION
Anti-IL-2 Ab (clones S4B6 and Jes61A12) and rat IgG2A isotype
control (2A3) were purchased from BioXcell (West Lebanon, NH,
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USA). Anti-IL-15 (M96) was a kind gift from Amgen (Seattle,
WA, USA). For IL-2 neutralization: 3- and 12-month-old mice
were injected i.p. with 170µg of S4B6 and Jes61A12, or with iso-
type control (2A3), on days 0, 1, 2, 4, 6, and sacrificed on day 7
and spleens were harvested. For IL-15 neutralization: 3- and 12-
month-old mice were injected i.p. with 25µg of M96 on days 0, 2,
4, 6, and sacrificed on day 7. IL-15 neutralization was confirmed
by assessing natural killer cells, which showed >60% deletion in
the spleen (data not shown).
CYCLOHEXIMIDE ASSAY
Splenocytes from either young (3 months) or old (22 months)
C57BL/6 mice were cultured with or without cycloheximide
(20µM; Sigma-Aldrich, St. Louis, MO, USA) for 8 h at 37° C.
Cells were stained for CD4, FoxP3, and Bim and analyzed by flow
cytometry. Percent decrease in Bim expression was determined
by comparing Bim expression between cells cultured with our
without cycloheximide.
QUANTITATIVE REAL-TIME PCR
Spleen cells from young (3 months) and old (22 months) FoxP3-
IRES-DTR-GFP mice were enriched for CD4+ cells using the
negative selection MACS CD4+ T cell Isolation Kit II (Mil-
tenyi Biotec) and stained with CD4 antibody. CD4+FoxP3GFP+
and CD4+FoxP3GFP− cells were then sorted by FACSAria (BD
Biosciences) and >90% purity was obtained for both popu-
lations. RNA was isolated from cells using the RNeasy Mini
Kit (Qiagen) and converted into cDNA using Superscript II
Reverse Transcriptase (Invitrogen, CA, USA). The primers used
for Bim were: 5′-ACAAACCCCAAGTCCTCCTT-3′ and 5′-GTTT
CGTTGAACTCGTCTCC-3′; and for the internal control L19:
5′-CCTGAAGGTCAAAGGGAATGTG-3′ and 5′-GCTTTCGTGC
TTCCTTGGTCT-3′. Quantitative real-time PCR was performed
with Roche LightCycler 480 SYBRGreen 1 Master Mix using the
Roche LightCycler 480 II instrument (Roche Diagnostics).
RESULTS
BIM PROGRESSIVELY DECREASES IN Treg WITH AGE
We have previously shown that Treg in aged mice have decreased
expression of Bim, and Bim−/− mice accrued Treg more rapidly,
together suggesting loss of Bim expression drives Treg accrual with
age (Chougnet et al., 2011). Here we investigated this in more
detail and found that the decrease in Bim expression with age is a
progressive process (Figure 1A). The major loss in Bim expression
is observed by 12 months (threefold; fourfold by 21 months), and
most significantly within the CD4+FoxP3+ population, not in the
CD4+FoxP3− population (Figure 1A) (Chougnet et al., 2011).
As Bim is subject to transcriptional, translational, and post-
translational control, we next determined the relative contri-
bution of these mechanisms. First, CD4+FoxP3GFP+ Treg and
CD4+FoxP3GFP− non-Treg were sorted from young (3 months)
and old (22 months) FoxP3GFP reporter mice (Kim et al., 2007).
Treg cells from old mice showed significantly decreased Bim mRNA
(∼2-fold), which was observed to a lesser extent in non-Treg
(Figure 1B). Next, to examine Bim protein turnover, splenocytes
from young and old mice were cultured with cycloheximide, an
antibiotic that inhibits translation. Interestingly, old FoxP3+ Treg
FIGURE 1 | Bim levels inTreg are progressively decreased with age. (A)
Splenocytes from 3 month (n=4), 12 month (n=4), and 21-month-old
(n=5) mice were stained with Abs against CD4, FoxP3, and Bim and
analyzed by flow cytometry. Results show the average mean fluorescent
intensity (MFI) of Bim in CD4+FoxP3+ T cells (±SE). The p values represent
the difference between 3 and 12 months; 12 and 21 months (Student’s t
test). (B) FoxP3GFP reporter mice were used to sort CD4+FoxP3GFP+ Treg,
CD4+FoxP3GFP− non-Treg from young (3 months; n=4) and old (22 months;
n=4) mice. Results show the relative expression of Bim mRNA in 3 and
22 months mice (±SE). The p values represent the difference between 3
and 22 months (Student’s t test). (C) Splenocytes from 3 months (n=4)
and 22 months (n=3) mice were cultured with or without cycloheximide
for 8 h at 37° C, and then stained for CD4, FoxP3, and Bim and analyzed by
flow cytometry. Results show the percent decrease in Bim expression
within CD4+FoxP3+ and CD4+FoxP3− cells cultured with cycloheximide
(±SE). Results are representative of at least two independent experiments.
cells had significantly greater Bim turnover compared to young
Treg (30 vs. 18%, respectively; Figure 1C). These data indicate that
both decreased Bim transcription and increased Bim turnover
likely contribute to the decreased Bim protein levels observed
with age.
Treg INTRINSIC LOSS OF BIM EXPRESSION PROMOTES ACCRUAL
WITH AGE
It remains unclear whether the effects of Bim on Treg accrual are
Treg intrinsic. To address this question, we crossed FoxP3-Cre mice
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(Rubtsov et al., 2008) with mice that have loxP flanked Bim on
both alleles (Bimf/f) (Figure 2A), and aged these FoxP3-Cre Bimf/f
mice to 6 months. Bim staining in FoxP3-Cre+Bimf/f mice was
comparable to Bim−/− mice, confirming efficient deletion of Bim
(Figure 2B). There was a small fraction of CD4+FoxP3– cells with
somewhat reduced expression of Bim, suggesting that some cells
may have deleted one or both alleles of Bim (Figure 2B). How-
ever, we did not observe loss of Bim in non-T cell populations
(i.e., CD11c+ or B220+ cells, data not shown). The frequency
of Treg in FoxP3-Cre+Bimf/f mice was increased at 2 months
of age, compared to either FoxP3-Cre– Bimf/f or Bim−/− mice
(Figure 2C). This increase in Treg at 2 months of age may be due
to increased thymic output in FoxP3-Cre+Bimf/f mice, as we see
increased frequencies and numbers of FoxP3+ cells in the thymi
of FoxP3-Cre+Bimf/f mice compared to FoxP3-Cre– Bimf/f (data
not shown). Importantly, by 6 months of age the frequency of Treg
in FoxP3-Cre+Bimf/f mice increased even further, reaching levels
observed in Bim−/− mice (Figure 2C). These data show that Treg
intrinsic loss of Bim is sufficient to promote Treg accumulation
with age.
BIM IS THE MAJOR PRO-APOPTOTIC PROTEIN RESPONSIBLE FOR Treg
HOMEOSTASIS
Although our data incriminate Bim as the major regulator of Treg
accumulation with age, we addressed the contribution of other
pro-apoptotic proteins in Treg survival, by using mice with T cell
specific deletion of Bax and Bak, Lck-Cre+Baxf/fBak−/−mice. Bax
and Bak are the downstream mediators of pro-apoptotic pro-
teins, and the deletion of both genes eliminates apoptosis through
the intrinsic pathway (Youle and Strasser, 2008). If other pro-
apoptotic proteins were critical in limiting Treg survival, then
Treg accrual in Lck-Cre+ mice would be significantly greater than
that observed in Bim−/− mice. One caveat of comparing Treg
accrual between Lck-Cre+Baxf/fBak−/− mice and Bim−/− mice
is that non-Treg loss of Bim could affect Treg homeostasis; how-
ever, our data in FoxP3-Cre+Bimf/f show that Treg-specific loss
of Bim is sufficient to drive accrual to levels similar to those
observed in Bim−/− mice. T cell loss of Bax and Bak resulted
in increased Treg accumulation at 15 months of age compared to
Lck-Cre− mice (20% increase compared to 10% increase, respec-
tively; Figure 2D). Importantly, the frequency of Treg was similar
in 15-month-old Lck-Cre+Baxf/fBak−/− mice and age-matched
Bim−/− mice, demonstrating that Bim is the major pro-apoptotic
protein controlling Treg survival.
BOTH SURVIVAL-DEPENDENT AND – INDEPENDENT MECHANISM(S)
CONTRIBUTE TO THE EMERGENCE OF BIMLO Treg
Old Bimlo Treg have increased survival ex vivo (Chougnet et al.,
2011); however, it remains unclear if Treg with lower Bim expres-
sion emerge in vivo because they are afforded a selective sur-
vival advantage. To test this, we examined Bim levels in Lck-
Cre+Baxf/fBak−/− Treg as their levels of Bim will be largely irrele-
vant to their survival. Notably, the levels of Bim were significantly
increased in Lck-Cre+ mice compared to Lck-Cre− mice, indicat-
ing Treg are able to tolerate higher levels of Bim in the absence
of Bax and Bak (Figure 3A). As expected, Bim levels in Treg from
FIGURE 2 | Bim is the dominant BH3-only molecule inTreg and its
effects onTreg homeostasis areTreg intrinsic. (A) A conditional Bim allele
was generated by targeting loxP sites upstream of exon 2 and downstream
of exon 4. (B,C) Cells from the lymph nodes of 2- and 6-month-old
FoxP3-Cre− Bimf/f, FoxP3-Cre+Bimf/f, and Bim−/− mice were stained for
CD4, FoxP3, and Bim and analyzed by flow cytometry. (B) Histograms
show the expression of Bim in CD4+FoxP3+ and CD4+FoxP3− T cells from
2-month-old mice. (C) Results show the frequency of CD4+ cells that are
FoxP3+ in 2 month (n=5/group) and 6-month-old mice (n=3–4/group;
±SE). The p values represent the difference between 2 and 6 months
(Student’s t test). Results are representative of two independent
experiments. (D) Splenocytes from Lck-Cre−Baxf/fBak−/− (n=3–5/group),
Lck-Cre+Baxf/fBak−/− (n=3–5/group), and Bim−/− (n=3–4/group), mice were
stained for CD4, FoxP3, and Bim and analyzed by flow. The Bim−/− mice
were analyzed in an independent experiment. Results show the frequency
of CD4+ cells that are FoxP3+ in 2- and 15-month-old mice (±SE). The p
values represent the difference between 2 and 15 months (Student’s t test).
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FIGURE 3 | Both environment and survival contribute to the
emergence of Bimlo Treg. Splenocytes from Lck-Cre−Baxf/fBak−/−
(n=3–5/group) and Lck-Cre+Baxf/fBak−/− (n=3–5/group) mice were stained
for CD4, FoxP3, and Bim and analyzed by flow. (A) Results show the Bim
MFI in CD4+FoxP3+ cells (±SE). The p values represent the difference
between 2 month-old and 15 month-old mice (Student’s t test). (B) Results
show the fold change in CD4+FoxP3+ Bim expression in 15 month
Lck-Cre−Baxf/fBak−/− and Lck-Cre+Baxf/fBak−/− mice compared to their
2 month counterparts. The p values represent the difference between
Lck-Cre− and Lck-Cre+ (Student’s t test).
15-month-old Lck-Cre− mice was significantly decreased com-
pared to their 2-month-old counterparts (Figures 3A,B). Bim was
also decreased in 15-month-old Lck-Cre+ mice (Figures 3A,B),
but the fold-decrease in Bim expression in Lck-Cre− mice was
greater than in Lck-Cre+ mice (threefold vs. twofold, respec-
tively; Figure 3B). Together, these data suggest that Bim levels are
controlled in Treg by both survival-dependent and independent
mechanisms.
AN AGED ENVIRONMENT PROMOTES THE EMERGENCE OF CD25LO Treg
Treg are described in the literature as CD4+FoxP3+ CD25hi, how-
ever there is a substantial population of CD4+FoxP3+ CD25lo cells
in young mice (∼10–20% of FoxP3+ cells; Figures 4A,B). Interest-
ingly, this population of CD25lo Treg expands with age, comprising
50% of the Treg population by middle-aged (Figures 4A,B) (Nish-
ioka et al., 2006; Lages et al., 2008). Importantly, while both
CD25lo and CD25hi Treg expand with age, the relative increase
in CD25lo Treg is much greater (Figure 4C). To assess whether
the aged environment drives CD25lo Treg accumulation, we adop-
tively transferred young (3–4 months) and old (19–23 months)
Treg into young (2 months) and aged (15 months) recipient mice
(Figure 4D). At 1.5 and 10 days later, recipient mice were sacri-
ficed and the frequency of CD25lo Treg from donors was assessed
(Figure 4E). Interestingly, when young cells were placed into aged
recipients, we observed an emergence of CD25lo Treg. Similarly,
CD25lo Treg were enriched slightly if old Treg were transferred
into aged mice. Increases in CD25lo Treg are likely not due to
increased proliferation as there was an equivalent percentage of
CD25lo and CD25hi Treg that were Ki67+ after transfer into aged
mice (Figure A1A in Appendix). Further, the total numbers of
CD25lo Treg were affected as the ratio of CD25hi to CD25lo Treg
decreased by day 10 post-transfer (Figure A1B in Appendix), sug-
gesting that CD25hi Treg may lose expression of CD25. On the
other hand, when young or old Treg were placed into young donors,
we did not see an enrichment of CD25lo Treg. Together, these data
strongly suggest that environmental changes with age support the
emergence of CD25lo Treg.
DECLINING IL-2 LEVELS WITH AGE FOSTERS THE EMERGENCE OF
CD25LOBIMLO Treg
IL-2 signaling is known to promote expression of its own receptor
CD25 (IL-2Rα) (Liao et al., 2013), and could be critical for main-
taining CD25hi Treg. As assessed in the serum, levels of IL-2 were
significantly decreased in middle-aged and old mice compared to
young mice (Figure 5A). Furthermore, Treg in IL-2−/− mice were
comprised almost entirely of CD25lo cells (Figure 5B). Interest-
ingly, CD25lo Treg were Bimlo at any age (Figure 5C), and this lower
expression of Bim may promote their increased accrual with age.
To assess whether IL-2 also controls Bim expression we measured
Bim levels in Treg from IL-2−/− mice. Strikingly, Bim levels were
significantly decreased in Treg from IL-2−/− mice (Figure 5D).
This loss of Bim expression occurred in the periphery, as Bim lev-
els in thymic Treg were similar between IL-2−/− and wild-type
mice (data not shown). To independently test the role of IL-2 in
maintaining CD25hiBimhi Treg, we neutralized IL-2 in young mice
(3 months), which resulted in decreased expression of Bim and an
enrichment of CD25lo Treg (Figures 5E,F). Also, the total num-
ber of Treg were not decreased after IL-2 neutralization, suggesting
that CD25hi Treg lose expression of CD25 (data not shown). Taken
together, these data show that IL-2 is critical for maintaining Treg
with a CD25hiBimhi phenotype, both in young and aged mice.
These data also suggest that reduced IL-2 with age promotes the
emergence of CD25loBimlo cells.
IL-15 CONTRIBUTES TO Treg HOMEOSTASIS IN MIDDLE-AGED MICE
We next examined the expression of receptors for other common
γ cytokines which can function redundantly with IL-2 to sup-
port Treg homeostasis and survival in young mice (Fontenot et al.,
2005a; Burchill et al., 2007; Bayer et al., 2008; Vang et al., 2008).
Although the expression of IL-7Rα (CD127) increases with age,
we previously showed that blocking CD127 signaling alone did
not affect Treg survival in 12-month-old mice (Chougnet et al.,
2011). IL-2Rβ (CD122) is a part of both the IL-2 and IL-15 recep-
tor, and its expression was significantly upregulated on Treg by
12 months of age (Figure 6A). Additionally, CD122 expression was
increased twofold on Treg in IL-2−/−mice (AVG MFI: WT= 1265;
IL-2−/−= 2378; p< 0.001) (Figure 6B). We therefore assessed
the role of IL-15 in Treg accumulation in middle-aged mice, as
increased Treg CD122 expression and increased CD25lo Treg by
12 months of age may reflect a change in Treg cytokine depen-
dency. While there was no difference in Treg frequency in young
IL-15−/− and wild-type mice, the frequency of Treg was signifi-
cantly reduced in IL-15−/− mice by 12 months of age (Figure 6C).
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FIGURE 4 | An aged environment promotes emergence of CD25lo Treg.
(A–C) Splenocytes from young (3 months; n=4), middle-aged (12 months;
n=4), and old (21 months; n=5) mice were stained for CD4, FoxP3, and
CD25 and analyzed by flow. (A) Histograms show the expression of CD25
on CD4+FoxP3+ cells. Percentages are the frequencies of CD4+FoxP3+ that
are CD25lo. (B) Results show the frequency of CD4+FoxP3+ cells that are
CD25lo (±SE). The p values represent the difference compared to
3-month-old mice (Student’s t test). (C) Results show the total number of
CD4+FoxP3+ cells that are CD25lo or CD25hi. The p values represent the
difference compared to 3-month-old mice (Student’s t test). Results are
representative of at least three independent experiments. (D,E)
CD4+FoxP3GFP+ T cells were sorted from splenocytes of young (3–4 months)
(Continued)
FIGURE 4 | Continued
and old (>18 months) CD45.2 FoxP3GFP reporter mice. About 5×105
CD4+FoxP3GFP+ cells were injected i.v. into young (2 months) and aged
(15 months) congenic CD45.1 mice. Mice were sacrificed at day 1.5
(n=3–5/group) and day 10 (n=3–5/group) post-injection. Cells from the
spleen were stained for CD4, FoxP3, CD25, and CD45.2 and analyzed by
flow. (E) Results show the frequency of CD4+CD45.2+FoxP3+GFP+ cells
that are CD25lo (±SE). The p values represent the difference between day
1.5 and 10 (Student’s t test).
FIGURE 5 | Declining IL-2 levels drives emergence of CD25loBimlo Treg.
(A) Serum IL-2 was determined by IVCCA. Results show the average serum
IL-2 levels from young (3–4 months; n=10), middle-aged (11–12 months;
n=11), and old (>15 months; n=9) mice (±SE). Results are representative
of 3 independent experiments. The p values represent the difference
compared to young (Student’s t test). (B,D) Splenocytes from 5-week-old
C57BL/6 wild-type (WT; n=4) and IL-2−/− (n=3) mice were stained for CD4,
FoxP3, CD25, and Bim and analyzed by flow. (B) Results show the
frequency of CD4+FoxP3+ cells that are CD25lo (±SE) and are
representative of two independent experiments. (C) Splenocytes from
3 month (n=4), 12 month (n=4), and 21-month-old (n=5) mice were
stained for CD4, FoxP3, CD25, and Bim and analyzed by flow. Results show
the Bim MFI of CD4+FoxP3+CD25lo cells and CD4+FoxP3+CD25hi cells
(±SE). The p values represent the difference between CD25lo and CD25hi
Treg (Student’s t test). (D) Results show the Bim MFI of CD4+FoxP3+ Treg
from WT and IL-2−/− mice (±SE) and are representative of two independent
experiments. (E,F)Three-month-old mice were injected with IL-2
neutralizing antibodies or IgG isotype control (n=4/group). Spleens were
harvested at day 7 and stained for CD4, FoxP3, CD25, and Bim. (E) Results
show the frequency of CD4+FoxP3+ cells that are CD25lo (±SE). (F) Results
show the Bim MFI of CD4+FoxP3+ Treg (±SE).
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FIGURE 6 | IL-15 antagonizes Bim to promoteTreg homeostasis in
middle-aged mice. Splenocytes from 3 month (n=4) and 12-month-old
(n=4) mice (A) or 5-week-old WT (n=4) and IL-2−/− (n=3) mice (B) were
stained for CD4, FoxP3, and CD122, and analyzed by flow. (A) Results show
the MFI of CD122 on CD4+FoxP3+ cells (±SE). (B) Histograms show
CD122 expression on CD4+FoxP3+ cells. The p value represents the
difference between the average CD122 MFI from WT and IL-2−/− mice
(Student’s t test). (C) Splenocytes from WT (n=3–4/group), IL-15−/−
(n=3/group), and IL-15−/− Bim−/− (n=2/group) were stained for CD4 and
FoxP3 and analyzed by flow. Results show the frequency of CD4+ cells that
are FoxP3+ (±SE) and are representative of two independent experiments.
Young (3 months; n=4/group) (D) and middle-aged (12 months;
n=5/group) (E) mice were injected with IL-2 and/or IL-15 neutralizing
antibody or with IgG isotype control. Spleens were harvested at day 7 and
stained for CD4, FoxP3, CD25, and Bim. (D,E) Results show the frequency
of CD4+ cells that are FoxP3+ (±SE). The p values represent the difference
between antibody treated and isotype control (Student’s t test).
Importantly, the additional loss of Bim (IL-15−/−Bim−/−), res-
cued the loss of Treg in middle-aged IL-15−/− mice (Figure 6C),
suggesting that IL-15 supports Treg homeostasis in aged mice by
combating Bim-mediated cell death.
To test whether IL-15 promotes Treg survival when IL-2 levels
decline, we neutralized IL-2 and/or IL-15 in young and middle-
aged mice. IL-2 neutralization in young mice (3 months) but not
middle-aged mice (12 months) resulted in a significant loss of Treg
(Figures 6D,E), supporting that IL-2 is less critical for Treg home-
ostasis in an aged environment. Conversely, IL-15 neutralization
in middle-aged mice resulted in a significant loss of Treg, which
was not observed in young mice (Figures 6D,E). Importantly, neu-
tralization of IL-2 and IL-15 did not result in further loss of Treg
compared to IL-15 neutralization alone (Figure 6E). Together, our
data suggests that in an aging environment, IL-15 supports Treg
survival in the face of declining IL-2.
DISCUSSION
Age-related immunosuppression is multi-factorial, encompassing
cell-intrinsic defects within T and B cells, as well as population
based defects such as a loss of naïve T cells and increased levels
of regulatory T cells (Valmori et al., 2005; Nishioka et al., 2006;
Sharma et al., 2006; Lages et al., 2008; Agius et al., 2009). Increased
levels of Treg are observed in both mice and humans and func-
tionally suppress T cell responses to both parasites (L. major) and
tumors (Sharma et al., 2006; Lages et al., 2008). We also recently
showed that Bim is a key controller of Treg homeostasis as Treg
accrual is accelerated in Bim-deficient (Bim−/−) mice (Chougnet
et al., 2011); although it was unclear if this was due to T cell spe-
cific effects of Bim in peripheral Treg. Here, we focused on further
understanding the mechanisms controlling Treg accrual in aging.
First, the germline deletion of Bim results in loss of Bim from
all tissues and it was possible that non-T cell expression of Bim
controls Treg homeostasis. In particular, the increased lifespan of
Bim-deficient dendritic cells (DC) (Chen et al., 2007) could con-
tribute to Treg accrual as DC can promote Treg homeostasis and
inducible Treg development (Yamazaki et al., 2003; Belkaid and
Oldenhove, 2008). Second, Bim−/− thymocytes are resistant to
negative selection (Bouillet et al., 2002) and such altered thymic
development in Bim−/− mice could skew the levels of Treg in
Bim−/− mice. By using FoxP3-Cre, which would likely not turn
on until after cells have committed to the Treg lineage and largely
at a point beyond negative selection (Fontenot et al., 2005b), we
avoided the effects of Bim in other tissues and the effects of Bim
on thymic development. Thus, our data clearly show that Treg-
specific loss of Bim is sufficient to drive Treg accrual with age and
strongly suggest that the normal decline of Bim expression seen in
wild-type mice promotes Treg accrual in aging mice.
While our data support Bim as a major controller of Treg home-
ostasis, we could not exclude potentially redundant roles for other
pro-apoptotic Bcl-2 family members. For instance, the additional
loss of Puma in Bim-deficient mice enhances T cell survival, sug-
gesting a redundant role for Puma with Bim in certain T cell
contexts (Erlacher et al., 2006; Gray et al., 2012). Moreover, we
have found that, like Bim, Puma levels are normally decreased as
mice age (data not shown). However, mice singly deficient in either
Bmf, Puma, Noxa, or Bad have no difference in Treg frequencies
in young mice (Tischner et al., 2012), while young Bim-deficient
mice have subtle, but significant increases in Treg (Zhan et al.,
2011; Tischner et al., 2012). Further, our finding that Treg accrual
was similar in aged Bim−/−mice and Lck-Cre+Baxf/fBak−/−mice
strongly suggest that Bim is the main negative regulator of Treg
homeostasis with age.
IL-2, on the other hand, is a major positive regulator of Treg
homeostasis as IL-2-deficient mice have significantly reduced Treg
(Fontenot et al., 2005a; Burchill et al., 2007; Barron et al., 2010).
Although it has been accepted for many years that IL-2 lev-
els decrease with age, this assumption was largely based upon a
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reduced production of IL-2 after in vitro stimulation of aged T
cells (Thoman and Weigle, 1981). To the best of our knowledge,
our study is the first demonstration that in vivo IL-2 levels are
decreased in aged mice. We acknowledge that serum IL-2 levels
may not fully reflect the in vivo bioavailability of IL-2, as IL-2
can bind to heparin sulfate on extracellular matrices (Wrenshall
and Platt, 1999), but we did not observe substantially increased
staining for IL-2 on spleen tissue from old mice (data not shown).
We previously proposed that continued IL-2 signaling drives the
expansion of Bimlo Treg, as exogenous IL-2 preferentially induced
proliferation and expansion of Bimlo Treg (Chougnet et al., 2011).
We note that these experiments were performed in young mice
that were given supraphysiologic levels of IL-2. Given that we now
know that IL-2 levels decline by middle-age, this model seems
less likely. Further, our new data clearly show that neutraliza-
tion of IL-2 and/or loss of IL-2 both lead to the accumulation
of CD25lo Treg and decreased the levels of Bim within these cells.
It does seem paradoxical that reduced levels of IL-2 in aged mice
would be associated with Treg accrual. However, our and oth-
ers data suggest that IL-2 and Bim antagonize one another to
regulate Treg homeostasis. For example, the absence of Bim can
restore Treg in IL-2-deficient mice (Barron et al., 2010) and we
found that limiting or restricting IL-2 results in the accrual of
Bimlo Treg. Thus, while it has been shown in cell lines that acute
withdrawal of IL-2 leads to increased Bim expression (Stahl et al.,
2002), chronic limiting IL-2 may select for Bimlo Treg. Further, we
show that the lack of IL-15 reduces the age-related accumulation
of Treg and that the additional loss of Bim restores Treg accrual.
We did not observe an effect of IL-15 on Bim expression directly,
but we cannot exclude that IL-15 acts to restrain the remaining
levels of Bim through another mechanism (i.e., Bim phosphoryla-
tion and turnover, induction of another anti-apoptotic molecule).
As IL-2 and IL-15 both signal through CD122 (IL-2/15Rβ) and
CD132 (common γ chain), it is possible that the decline of IL-
2 favors the emergence of CD25loBimlo Treg because these cells
are selected to survive and are maintained by IL-2-independent
mechanisms, such as IL-15 (Fontenot et al., 2005a; Burchill et al.,
2007).
While IL-2 and IL-15 signal through the same receptors, they
can have divergent effects on T cells. For example, both IL-2 and
IL-15 can activate the STAT5 and PI-3K/AKT pathways (Wald-
mann, 2006). In CD8+ T cells, the magnitude of STAT5 activation
by IL-2 and IL-15 is similar, although IL-2 drives more prolonged
STAT5 activation (Castro et al., 2011). Further, while both IL-2
and IL-15 can activate PI-3K/AKT/mTOR, IL-2 drives both an
increased magnitude and persistence of mTOR activation com-
pared to IL-15 (Cornish et al., 2006; Castro et al., 2011). Recent
work has shown that unrestrained activation of mTORC1 in T cells
lead to significantly increased Bim expression (Yang et al., 2011).
Thus, it is possible that the differential activation of mTORC1 by
IL-2 and IL-15 may underlie Bim regulation in Treg. However, it
remains to be determined whether or not the degree to which the
mechanisms are operative in Treg cells.
Bim is also regulated at the transcriptional level by the FOXO
family of transcription factors. FOXO transcription factors pro-
mote Bim expression in T cells in response to cytokine withdrawal
(Stahl et al., 2002; Salih and Brunet, 2008). FOXO(s) are inhibited
by PI-3K/AKT activation, which leads to FOXO phosphorylation
and sequestration from the nucleus (Salih and Brunet, 2008). Con-
sistent with this, we found that in vivo IL-2 administration to
young mice resulted in accrual of Bimlo Treg (Chougnet et al.,
2011). However, in aged mice we found decreased in vivo IL-2
levels and decreased Bim expression, which are inconsistent with a
role for FOXO transcription factor control of Bim. Interestingly,we
also find that FOXO1 and FOXO3a levels themselves are decreased
in aged Treg (data not shown). As mentioned earlier, levels of
Puma, another FOXO target are also decreased in aged Treg, rais-
ing the possibility that decreased levels of FOXO molecules may
contribute to decreased expression of Bim.
Certainly, a survival advantage contributes to the accrual of Treg
with low Bim expression as Treg with higher levels of Bim accu-
mulate in mice whose Treg cannot undergo apoptosis (i.e., T cell-
specific Bax/Bak-deficient mice). One factor that may promote
selection of Bimlo Treg is the decreased expression of Bcl-2 and
Mcl-1 observed in aged Treg (Chougnet et al., 2011). Indeed, Bcl-
2 is the major anti-apoptotic reported to combat Bim-mediated
death in T cells (Wojciechowski et al., 2007), and Bim and Bcl-2
have been shown to affect the expression of each other (Jorgensen
et al., 2007). Further, we recently showed in CD8+ T cells that inhi-
bition or loss of Bcl-2 selected for effector CD8+ T cells expressing
low levels of Bim (Kurtulus et al., 2011). Thus, decreased expres-
sion of Bcl-2 with age may prompt the selection of Bimlo Treg.
However, it is also clear that, relative to their young counterparts,
Bim levels decline even in T cell-specific Bax/Bak-deficient mice,
suggesting that levels of Bim may be controlled by non-survival
related mechanisms as well. An alternative,and not mutually exclu-
sive, explanation is that decreased Bim mRNA levels in aged Treg
may be due to epigenetic modification of the Bim promoter. The
Bim promoter is CpG rich, and there is evidence that Bim expres-
sion can be repressed through hypermethylation (Paschos et al.,
2009; San Jose-Eneriz et al., 2009; De Bruyne et al., 2010; Richter-
Larrea et al., 2010). Furthermore, increased CpG methylation is
a trait observed in aged cells (Golbus et al., 1990; Issa, 2003).
Thus, as epigenetic modifications can be inherited, Bim promoter
methylation may aid in the prolonged survival of aged Treg. We are
currently determining whether epigenetic and/or transcriptional
repression affects Bim expression in aged Treg.
While the exact mechanisms leading to decreased Treg Bim
expression with age are still unclear, progressive loss of Bim expres-
sion occurs in both CD25lo and CD25hi Treg and this loss is likely
sufficient to drive accrual of both populations with age. Further-
more, it is likely the lower expression of Bim in CD25lo Treg that
affords these cells a survival advantage over CD25hi Treg, especially
when IL-2 becomes limiting, and promotes increased CD25lo Treg
accrual. Indeed, not until IL-2 levels have declined do we begin to
see the emergence of CD25lo Treg in middle-aged mice. Because
IL-2 promotes the expression of CD25 (Liao et al., 2013), there is
likely still enough bioavailable IL-2 present in aged mice to main-
tain CD25 expression on the accumulated CD25hi Treg population.
Thus, it is likely that both reduced IL-2 signaling as well as other
mechanism(s) (i.e., Bim promoter epigenetics) contribute to the
control of Bim expression with age.
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In this study, we show that Treg loss of Bim drives accrual
with age, while IL-15 is critical for aged Treg survival in the
face of declining IL-2. We have shown here that Treg accrual is
driven by several non-mutually exclusive mechanisms, including:
(i) decreased Bim transcription, (ii) decreased Bim protein half-
life, (iii) selection of Bimlo Treg due to a survival advantage, and
(iv) a switch in cytokine dependency (from IL-2 to IL-15) with
age. Future studies will focus on the mechanisms driving decreased
Bim gene expression and protein half-life (i.e., promoter epigenet-
ics, AKT/FOXO pathway), which may expose potential therapeutic
targets for manipulating Bim expression and Treg accrual. The
ability to moderately manipulate Treg homeostasis and accrual,
without inducing inflammation and autoimmune responses, may
provide a potential therapy for enhancing immune competence in
the elderly.
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APPENDIX
FIGUREA1 | Absolute numbers and proliferation ofTreg post-adoptive
transfer. CD+FoxP3GFP+ T cells were sorted from splenocytes of young
(3–4 months) and old (>18 months) CD45.2 FoxP3GFP reporter mice. About
5×105 CD4+FoxP3GFP+ cells were injected i.v. into young (2 months) and
aged (15 months) congenic CD45.1 mice. Mice were sacrificed at day 1.5
(n=3–5/group) and day 10 (n=3–5/group) post-injection. Cells from the
spleen were stained for CD4, CD25, CD45.2, and intracellularly for FoxP3
and Ki67 and analyzed by flow. (A) Results show the frequency of
CD4+CD45.2+FoxP3+GFP+CD25lo and CD25hi cells that are Ki67+ on day 10
post-transfer into aged recipient mice (±SE). (B) Results show the numbers
ratio of CD25hi to CD25lo CD4+CD45.2+FoxP3+GFP+ cells (±SE).
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